IACUC Veterinarians

As a veterinarian with more than 20 years of institutional animal care and use committee (IACUC) experience, I wish to comment on your article (R. Finn, The Scientist, May 26, 1997, page 1). I am perplexed by the statement by Harry Rozmiarek that "the research investigator is paying the bill." From a literal viewpoint, rarely if ever does the investigator pay for animal care and use. It is the public-through taxation for government-supported research, contributions to charitable foundations th

Written byStephen Dubin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

As a veterinarian with more than 20 years of institutional animal care and use committee (IACUC) experience, I wish to comment on your article (R. Finn, The Scientist, May 26, 1997, page 1).

I am perplexed by the statement by Harry Rozmiarek that "the research investigator is paying the bill." From a literal viewpoint, rarely if ever does the investigator pay for animal care and use. It is the public-through taxation for government-supported research, contributions to charitable foundations that fund research, and the purchase of drugs and other consumer products-that actually pays the bills.

Rozmiarek's statement does, however, underline the conflicts that veterinarians must face in serving on an IACUC or as a laboratory animal veterinarian. It should be noted that this is not a new situation, nor is it unique to the laboratory and classroom. Veterinarians have long been faced with the sometimes conflicting interests of a food animal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies